Related Experiment Video

Updated: Jul 12, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.5K

The ErbB Signaling Network and Its Potential Role in Endometrial Cancer

Georgios Androutsopoulos1,2, Ioanna Styliara2, Evgenia Zarogianni2

  • 1Gynaecological Oncology Unit, Department of Obstetrics and Gynaecology, School of Medicine, University of Patras, 26504 Rion, Greece.

Epigenomes
|October 24, 2023
PubMed

Insights

Endometrial cancer (EC) involves key signaling pathways like EGF. ErbB receptor expression differs in EC, with ErbB-2 potentially guiding targeted therapies for aggressive subtypes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gynecologic Oncology

Background:

  • Endometrial cancer (EC) is a prevalent female reproductive system malignancy.
  • Updated EC classification highlights roles of PIK3CA-PIK3R1-PTEN and RTK/RAS/β-catenin signaling pathways.
  • Epidermal Growth Factor (EGF) system signaling network is implicated in cancer pathogenesis.

Purpose of the Study:

  • To investigate the role of ErbB receptors in endometrial cancer.
  • To analyze differences in ErbB receptor expression between EC and normal endometrium.
  • To explore the potential of ErbB-targeted therapies in specific EC subgroups.

Main Methods:

  • Analysis of ErbB receptor expression in endometrial cancer tissues.
  • Comparison of gene expression in EC versus premenopausal and postmenopausal endometrium.
  • Correlation of ErbB-2 expression with EC histologic subtypes and clinical behavior.

Main Results:

  • ErbB receptor expression patterns differ significantly in EC compared to normal endometrium.
  • Increased transcriptional activity of ErbB encoding genes observed in EC cells.
  • ErbB-2 receptor expression is more frequent in aggressive EC subtypes (papillary serous, clear cell).

Conclusions:

  • ErbB receptor expression is altered in endometrial cancer.
  • ErbB-2 overexpression in aggressive EC subtypes suggests potential for targeted therapy.
  • Further research into ErbB-targeted therapies for specific EC subgroups is warranted.
Keywords:
EGF systemErbB receptorscarcinogenesisclinical roleendometrial cancerexpression profilephysiologysignaling pathways

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.3K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.0K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K